Rationale and Objectives. Both monomeric and dimeric ionic radio contr
ast media (CM) have been shown to be more anticoagulant than nonionic
monomeric CM. Iodixanol is a relatively new nonionic dimeric contrast
medium. We investigated whether the dimeric structure of iodixanol wou
ld produce the same level of anticoagulation that has been observed us
ing nonionic monomeric CM. Methods. We used a global screening device
that operates under physiologic flow conditions to monitor the effects
of iodixanol on in vitro bleeding time (IVBT). This flow dynamic tech
nique perfuses nonanticoagulated whole blood through a hollow fiber de
vice. A leak in the fiber is created by a precision needle, and the re
sulting pressure fluctuations within the fiber are monitored to examin
e the ability of the hemostatic system to close the leak by forming a
stable platelet plug. Results. In 20 donors, iodixanol (25% CM/blood,
v/v) was shown to lengthen the mean IVBT (18.74 min) compared with the
normal blood mean IVBT (4.24 min). Conclusion. The addition of dimeri
c iodixanol to normal blood affects the NET in the same manner as noni
onic monomeric CM (ioversol, iopamidol, and iohexol).